Research highlights
Vaccine research across LSHTM is highly multi-disciplinary and covers the full pipeline from vaccine development to modelling, implementation, and evaluation.
Our three themes of ‘innovation’, ‘implementation’, and ‘equity’ act as focal points for our activities as a Centre, although individual researchers and projects are likely to sit across these themes, reflecting the multi-faceted nature of modern vaccine research.
See below for a selection of vaccine-related research spanning our three key themes undertaken at the Vaccine Centre and partner institutions.
The Vaccine Confidence Project was established in 2010 at the London School of Hygiene & Tropical Medicine to better understand growing vaccine scepticism around the world.
The Modelling and Economic Evaluation of Vaccines group aims to develop vaccine impact models to understand the immunological, epidemiological, and economic dynamics of vaccination, and generate evidence to inform vaccine policy and practice at the global, regional, and national levels.
The HPRU in Vaccines and Immunisation looks at the effectiveness and safety of vaccines, how many people are being vaccinated, disease trends, the impact of introducing new vaccines and people's perceptions of vaccines and access.
VaxHub brings together world-leading experts in vaccinology, synthetic biology, biochemistry, materials science, and systems engineering. The complementary research programmes are non-disease-specific, focusing on the development and optimisation of various vaccine platform technologies.
Through key epidemiology and clinical trials, our team of vaccine researchers are working at all stages of the vaccine development to contribute to the development and implementation of relevant vaccines, and context-specific techniques and measures for harnessing vaccine response and efficacy.
The vaccines and immunity theme at the MRC Unit The Gambia works towards a better understanding of natural or vaccine-induced immunity implicated in defence against serious infectious diseases. Our studies in lab and field aim to inform the design of novel vaccines and maximise vaccine impact.
IMPRINT is a network focusing on maternal and neonatal immunisation. It aims to build a sustainable network of stakeholders from basic science, immunology, vaccinology, social sciences, industry, public health and national and international policy makers, to tackle the challenges in the best use of vaccines in pregnancy and in newborns, and in the long term to improve maternal and newborn health.
